Keytruda Qlex 00006-3083
Generic: Pembrolizumab And Berahyaluronidase Alfa-Pmph
Product NDC
00006-3083- Manufacturer
- Merck Sharp & Dohme Llc
- Dosage Form
- Injection, Solution
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- September 19, 2025
- Listing Expires
- December 31, 2027
- Application
- BLA761467
Need to source Keytruda Qlex? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Berahyaluronidase Alfa | 2000 U/mL |
| Pembrolizumab | 165 mg/mL |
Drug Class
Programmed Death Receptor-1 Blocking Antibody [EPC]Endoglycosidase [EPC]Endoglycosidase [EPC]
Packaging Options(1)
1 VIAL in 1 CARTON (0006-3083-01) / 2.4 mL in 1 VIAL (0006-3083-99)